PredictBy’s Post

Yesterday was the kick-off meeting of our collaborative project #RHU #SyStInn with Hospices Civils de Lyon - HCL CRCL Centre de Recherche en Cancérologie de Lyon Centre Léon Bérard Université Claude Bernard Lyon 1 Thanks to the project leaders Charles Dumontet Juliette Humeau Vanessa Paduano for organizing this first project meeting and sharing our first results 🔬 Thanks to all the HEPHAISTOS-Pharma team participating to the project Martine Caroff Simon Pico Jerome Kerzerho Alexey Novikov Capucine Phelip This Project is supported by a French government #Grant managed by the ANR (Agence nationale de la recherche) under the #France2030 program, reference ANR-23-RHUS-0003. The project will last 5 years and take us up to clinical phase 2.

𝐇𝐨𝐰 𝐝𝐨 𝐰𝐞 𝐛𝐚𝐥𝐚𝐧𝐜𝐞 𝐭𝐡𝐞 𝐬𝐨𝐜𝐢𝐚𝐥 𝐚𝐧𝐝 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐛𝐢𝐨𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐰𝐢𝐭𝐡 𝐢𝐭𝐬 𝐞𝐜𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐢𝐦𝐩𝐚𝐜𝐭? During Utrecht Science Week, a diverse panel of experts will delve into how we can enhance the societal impact of research while minimizing waste. More information en registration👇

🌱Seed Call Announcement! We're excited to announce a new round of Seed Funding: "Embracing a Transdisciplinary Approach to Drive Preventive Health Transformations." Are you a researcher at TU/e, WUR, UU or UMCU and passionate about advancing preventive health through collaboration and innovative research? The institute 4 Preventive Health (i4PH) offers a unique opportunity for researchers to catalyze collaborative projects and drive impact in the preventive health domain. 🌍 Our Vision: A Healthier Netherlands For All Aligned with Health Holland's agenda, we aim to increase healthy lifespans by 5 years and reduce health disparities by 30% by 2040. Together, we're focusing on critical life stages and driving system-wide changes in preventive health. 🔍 Explore the Research Themes - Healthy Start: Supporting children and families from conception to independence - Healthy Living Environments: Enhancing health through better built, social, and food environments - The Future of Cancer: Advancing cancer prevention, treatment, and survivor support - Health @ Home: Empowering elderly and vulnerable individuals through technological innovations 💡 Apply For Funding Transform your ideas into impactful projects! We're offering up to €50,000 per proposal to develop tangible outcomes that drive meaningful change. 📅 Deadlines and Details Applications open July 15th and close October 18th. Visit the i4PH website for Terms and Conditions and to apply for the Seed Fund. More information: https://lnkd.in/et4qjD95 EWUU alliance (TU/e, WUR, UU, UMC Utrecht) Technische Universiteit Eindhoven Wageningen University & Research Universiteit Utrecht UMC Utrecht

✨ This week the stars aligned between #Boston and #Basel, with huge developments at two major research centers focused on the potential of the immune system to prevent, diagnose, and treat diseases. 🇺🇸 In the Boston area, the Ragon Institute of Mass General, MIT, and Harvard celebrated the opening of its new headquarters, located in the heart of Cambridge’s Kendall Square. Founded in 2009, the institute brings together scientists and engineers from its three member institutions to better understand the immune system and support human health. On June 17, Our CEO Benjamin Bollmann attended the grand opening of the new building in the presence of Massachusetts Governor Maura Healy, as well as Anne Klibanski, president and CEO of Mass General Brigham, Sally Kornbluth, president of the Massachusetts Institute of Technology, Alan Garber, interim president of Harvard University, and Bruce D Walker, director of the Ragon Institute. 🇨🇭 On June 18, the new Botnar Institute of Immune Engineering – BIIE launched in Basel, with the goal of developing novel immune-based diagnostics and therapeutics and addressing gaps in advanced healthcare technologies. Supported by a $1 billion endowment by the Fondation Botnar, the institute already has partnerships planned with ETH Zürich and the University of Oxford, with more to be announced. For now, the institute will be hosted by the ETH-Department of Biosystems Science and Engineering (D-BSSE), until it moves into a purpose-built research facility for up to 300 scientists at the Switzerland Innovation Park Basel Area in 2027. 🇺🇸🇨🇭 We look forward to a bright future for immune-based innovation in Boston and Basel, and to expanding collaboration between these two global #lifesciences hubs! Alexander Schulze Stephen Wilson, PhD Georg Holländer Basel Area Business & Innovation Kanton Basel-Landschaft #ImmuneEngineering #Innovation #GlobalVision #Immunology #ChildAndAdolescentHealth

This article does a great job describing the challenges researchers face trying to sustain funding. The focus is mostly on biomedical research but we struggle with these same issues in the social sciences. Bridge funding could really help ease the stress and burden, but I haven’t seen opportunities for these resources in social science research. I hope we can find ways to change this situation and address the inefficiencies of grant funding.

Two crucial topics, health and sustainability, will be at focus at the Global Science Summit in Denmark, hosted by the Novo Nordisk Foundation.

📢 Read BBMRI-ERIC’s six key messages for the next European Framework Programme (FP10) in this post. And get the full position paper here: 🔗 https://lnkd.in/d3qv8xkD This position paper aims to ensure that FP10 priorities incorporate key fields of health and life science research building on Research Infrastructures, like the European biobanking infrastructure. ❗️#FP10 topic 1: Focus on a “One Health” approach in research. “One Health” promotes cross-disciplinary scientific collaboration. Empowering research in “One Health” using existing ERICs will drive innovation at the intersection of human, animal, and environmental health.   ❗️#FP10 topic 2: Accelerate and advance research in the fields of cancer, rare diseases and paediatrics. Combatting cancer must remain a central focus for EU policy and funding to foster synergies of collaborative research initiatives in cancer in FP10.   ❗️#FP10 topic 3: Shape the European Health Data Space (EHDS). The EHDS is paramount for future breakthroughs. BBMRI-ERIC, part of the EHDS2Pilot project, explores how to optimally support EHDS implementation regarding the reuse of health data for research and policymaking.   ❗️#FP10 topic 4: Strengthen international research partnerships. Working towards global health strategies implies expanding research partnerships across all continents. Funding new collaborations in FP10 will help to align research efforts to jointly address key challenges.   ❗️#FP10 topic 5: Consolidate research efforts by enabling access to different funding initiatives. Confining Research Infrastructures to their Work Programmes is a lost chance for a wider use of their resources. FP10 needs overarching concepts across domains and dataspaces.   ❗️#FP10 topic 6: Avoid further diversification of the RI landscape. We call upon the EC to channel resources and efforts towards fortifying existing ERICs as strategic assets, and encourage close collaboration with initiatives to avoid fragmentation of the RI landscape.  

🌍🧬 Thanks to generous donors EB Research Partnership is able to fund resources, like the EB Clinical Characterization and Outcomes Database, that accelerate EB research and power groundbreaking studies such as this one. By enabling broad-scale analysis of EB wound cultures these resources empower researchers to unlock critical insights toward effective treatments. This progress is made possible through the collaboration of the EB Research Consortium, uniting the best minds in the field. 💙 Learn more here: ebresearch.org/consortia

🎉 Exciting Milestone: Research Impact on ResearchGate! 🎉 I am thrilled to share a significant milestone in my research journey. My research items have been read over 600 times on ResearchGate! This achievement underscores the growing interest and importance of our work in the field of liver diseases. 🎉Research Focus Areas: 🎉Hepatocellular Carcinoma (HCC): Investigating tumor markers and their role in the early detection and management of liver cancer. 🎉Cirrhosis: Exploring the progression, complications, and potential therapeutic interventions for liver cirrhosis. 🎉Reference Intervals: Establishing and validating reference intervals for various biomarkers to improve diagnostic accuracy and patient outcomes. 🎉Key Highlights: Tumor Markers for HCC: Our research is paving the way for better diagnostic tools, allowing for earlier detection and more effective treatment strategies for hepatocellular carcinoma. 🎉Advancements in Cirrhosis Management: Through comprehensive studies, we aim to enhance the understanding of cirrhosis progression and identify potential therapeutic targets to improve patient care. 🎉Improved Reference Intervals: By refining reference intervals for critical biomarkers, we strive to enhance diagnostic precision, ultimately benefiting clinical practice and patient outcomes. 🎉Gratitude and Future Directions: I am deeply grateful for the support and engagement from the research community. Your interest and collaboration are vital as we continue to advance our understanding of liver diseases. Moving forward, I am committed to furthering this research and contributing to meaningful advancements in the diagnosis and treatment of liver conditions. 🎉Join the Conversation: I invite fellow researchers, clinicians, and students to connect and collaborate. Together, we can push the boundaries of liver disease research and make a lasting impact on patient health. #ResearchMilestone #LiverDiseaseResearch #HepatocellularCarcinoma #Cirrhosis #TumorMarkers #ReferenceIntervals #ResearchGate #AcademicImpact #HealthcareInnovation #MedicalResearch #LiverHealth #BiomedicalResearch #ClinicalResearch #EarlyDetection #PatientCare #HealthScience #ScienceInAction #ResearchCommunity Thank you to everyone who has supported this journey. Here’s to many more milestones and breakthroughs ahead!

🎉 Momentous day at Utrecht University! Founding partner of the #BioMed21 Collaboration, Humane Society International, represented by Helder Constantino, Director, Research Policy, attended the launch of the groundbreaking CPBT Centre for Animal-Free Biomedical Translation! The Dutch National Growth Fund (NGF) has invested €124.5 million in this initiative, which is set to revolutionize biomedical research. Key aims of the CPBT:   ⭐ Develop and accelerate animal-free biomedical innovations through strategic collaborations ⭐ Focus initial research on critical diseases: ALS, cystic fibrosis, osteoarthritis, and respiratory conditions ⭐ Implement advanced research methods and tools with researchers and companies ⭐ Offer education, training, advice, and support to enhance the acceptance and use of animal-free biomedical innovations ⭐ Accelerate the transition to animal-free testing while strengthening the Dutch economy through an integrated program   HSI is proud to be an official partner of this innovative centre, which aims "to improve and accelerate the transition of new biomedical innovations to patients and users, at lower costs, and without the use of animals."   Congratulations to the CPBT team on this exciting launch! We eagerly anticipate the discoveries and advancements that will emerge from this visionary initiative. 🔬🧬🧫 Pictured are Daniela Salvatori, Helder Constantino and Cyrille Krul.   #AnimalFreeScience #AnimalFreeResearch #NonAnimalMethods #21stCenturyBiomedicalResearch #HumanHealth #Innovation #BiomedicalResearch